Atlas Trials

A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus

Clinical trial NCT03586830 · COMPLETED

Trial details

NCT number
NCT03586830
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Obesity and Diabetes Mellitus, Type 2
Start date
2018-06-26
Primary completion
2019-04-05
Enrollment
196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.